The Use of Localised Vaginal Drug Delivery as Part of a Neoadjuvant Chemotherapy Strategy in the Treatment of Cervical Cancer

Journal Title: Gynecology and Obstetrics Research – Open Journal - Year 2015, Vol 2, Issue 1

Abstract

Cervical cancer is the third most prevalent cancer in women globally, with 529,000 diagnosis and 275,000 deaths each year. It is especially prevalent in developing countries where approximately 85% of cases arise due to the lack of cervical cancer prevention and control programs. In developed countries, where women have access to resources capable of detecting and treating precancerous lesions, the number of cases is reduced by approximately 80%.1 Cervical cancer can be characterised, depending on how far it has spread, from stage 0 (precancerous), also called Cervical Intraepithelial Neoplasia (CIN), where abnormal cells are found in the innermost lining of the cervix and have the potential to become cancerous, through to stage 4, where the cancer has spread to the bladder, rectum or other parts of the body, such as the lungs. In developed countries, there are currently two methods used to prevent cervical cancer from developing to an advanced stage: (1) the distribution of HPV vaccines that are mainly directed against HPV types 16 and 182 and (2) screening methods, such as Papanicolaou test (Pap smear), which involves the collection of exfoliated cells from the cervix, which are then examined for cellular abnormalities. This enables identification of CIN before they begin to develop into cervical cancer.

Authors and Affiliations

Christopher McConville

Keywords

Related Articles

Cryptococcal Meningitis in Pregnancy, the Neglected Diagnosis: A Case Report

Introduction: Cryptococcal meningitis is an opportunistic infection of human immunodeficiency virus infection and acquired immune deficiency syndrome (HIV/AIDS) that can cause maternal and fetal mortality and morbidity....

Heterotopic Pregnancy

Heterotopic pregnancy is a rare gynaecological condition whereby there is a presence of an intrauterine pregnancy and extrauterine pregnancy at the same time. It was first defined by Duverney in 1708 as an autopsy findin...

Developmental Exposure to Endocrine Disrupting Chemicals Alters the Epigenome: Identification of Reprogrammed Targets

Endocrine disruptions induced by environmental toxicants have placed an immense burden on society to properly diagnose, treat and attempt to alleviate symptoms and disease. Environmental exposures during critical periods...

Analyzing Pregnancy Costs with Finite Mixture Models: An Opportunity to More Adequately Accommodate the Presenceof Patient Data Heterogeneity

The choice of a model in the analysis of patient health care costs and utilization is critical for a clear understanding of the behavior and estimation of quantities like incremental costs or cost-effectiveness. In study...

Ovarian Cystectomy for Huge Mature Cystic Teratoma Developed in Less than Five Years: A Case Report

Cystic ovarian teratomas, also known as dermoid cysts, are the most common benign ovarian germ cell tumors. They typically occur during reproductive age. Due to the readable accessibility to ultrasonography, the finding...

Download PDF file
  • EP ID EP553476
  • DOI 10.17140/GOROJ-2-106
  • Views 175
  • Downloads 0

How To Cite

Christopher McConville (2015). The Use of Localised Vaginal Drug Delivery as Part of a Neoadjuvant Chemotherapy Strategy in the Treatment of Cervical Cancer. Gynecology and Obstetrics Research – Open Journal, 2(1), 26-28. https://europub.co.uk/articles/-A-553476